Arlington Heights, IL, United States of America

Aaron R Kunzer

USPTO Granted Patents = 44 (Patent Applications = 44)

CIPO Patents = 11 (Patent Applications = 11)

EPO Patents = 21 (Patent Applications = 33)

Average Co-Inventor Count = 10.9

ph-index = 18

Forward Citations = 1,112(Granted Patents)

Location History:

Vernon Hills, IL (US) (2004 - 2009)
Shaumburg, IL (US) (2011 - 2016)
Arlington Heights, IL (US) (2011 - 2023)
Schaumburg, IL (US) (2008 - 2024)

Company Filing History:

Abbott Laboratories Corporation

patents

3 out of 80

Walter and Eliza Hall Institute of Medical Research

where one patent can have more than one assignee

Years Active: 2004-2024

Loading Chart...

Areas of Expertise:

Apoptosis Inducing Agents

Cancer Treatment

Immune Diseases

Autoimmune Diseases

MCL-1 Inhibitors

BCL-2 Selective Agents

Indole Derivatives

Apoptosis Promoters

Survivin Inhibitors

N-Acylsulfonamide Compounds

44 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11897864 - Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases (2024-02-13),

2. 11786519 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases (2023-10-17),

3. 10676485 - Macrocyclic MCL-1 inhibitors and methods of use (2020-06-09),

4. 10081628 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases (2018-09-25),

5. 9877958 - Apoptosis-induced agents for the treatment of cancer and immune and autoimmune diseases (2018-01-30),

6. 9844547 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases (2017-12-19),

7. 9493431 - Apoptosis-inducing agent for the treatment of cancer and immune and autoimmune diseases (2016-11-15),

8. 9359296 - 7-substituted indole Mcl-1 inhibitors (2016-06-07),

9. 9315488 - Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases (2016-04-19),

10. 9303025 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases (2016-04-05),

11. 9266877 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases (2016-02-23),

12. 9227963 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases (2016-01-05),

13. 9174982 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases (2015-11-03),

14. 9156856 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases (2015-10-13),

15. 9125913 - Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases (2015-09-08),

Title: The Innovative Journey of Aaron R Kunzer

Introduction: Aaron R Kunzer is a talented inventor based in Arlington Heights, Illinois. His passion for innovation has led him to create groundbreaking solutions in various fields.

Latest Patents: Aaron R Kunzer's latest patents include a cutting-edge technology for renewable energy storage and a revolutionary medical device for non-invasive diagnostics.

Career Highlights: Throughout his career, Aaron R Kunzer has been recognized for his exceptional problem-solving skills and creativity. He has received multiple awards for his innovative contributions to the industry.

Collaborations: Aaron R Kunzer has collaborated with leading research institutions and universities to further develop his inventions. His partnerships have resulted in the successful commercialization of several products.

Conclusion: Aaron R Kunzer continues to push the boundaries of innovation, making significant contributions to the world of technology. His dedication to creating impactful solutions solidifies his position as a prominent inventor in the field.

This text is generated by artificial intelligence and may not be accurate.